Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and actinium

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with actinium in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Studies
(actinium)		Trials
(actinium)		Recent Studies (post-2010) (actinium)
638312432401142

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bausbacher, N; Miederer, M; Pektor, S; Pfannkuchen, N; Rosch, F1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and actinium

ArticleYear
    Current radiopharmaceuticals, 2018, Volume: 11, Issue:3

    Topics: Actinium; Alpha Particles; Animals; Bone Density Conservation Agents; Bone Neoplasms; Chelating Agents; Heterocyclic Compounds; Kidney; Organometallic Compounds; Radioimmunotherapy; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution; Zoledronic Acid

2018